Biomark Capital
Venture capitalGreenwich · Series A–Late Stage · 4 people tracked
Investment thesis
Biomark Capital invests in early through late-stage life science companies focused on diagnostics, therapeutics, medical devices, and digital health. The firm provides funding and operational support to its portfolio companies.
Team · 4 people
from public directories
Frequently asked questions
- What stage does Biomark Capital invest at?
- Biomark Capital invests at the Series A, Series B, Series C, Late Stage stages.
- What is Biomark Capital's typical check size?
- Biomark Capital typically writes checks of $5M – $10M.
- What sectors does Biomark Capital focus on?
- Biomark Capital focuses on Biotech, Enterprise Software, Healthtech, Medical Devices.
- Where is Biomark Capital located?
- Biomark Capital is headquartered in Greenwich, US.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
New Science Ventures (NSV) is a venture capital firm based in Connecticut and London that backs companies applying novel scientific approaches in the life sciences and information technology sectors.
CIBC is a Canadian retail and commercial bank offering personal banking, investing (CIBC Investor's Edge), and financial advisory services to consumers.